Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for establishing osteoporosis risk prediction model of type 2 diabetic patient and application thereof

A type 2 diabetes, predictive model technology, applied in the fields of biotechnology and clinical medicine, can solve problems such as difficulty in obtaining bone mineral density results, affecting the diagnosis and treatment process, and inability to perform detection, so as to relieve medical economic pressure, reduce clinical work costs, and save money. The effect of medical expenses

Pending Publication Date: 2021-01-01
SHANGHAI TONGJI HOSPITAL
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First of all, bone densitometers are not fully popular in China, and only tertiary hospitals in big cities have testing conditions; second, bone densitometers are based on X-ray scanning imaging, and patients avoid bone density testing because they are worried about radiation; The detection process of the densitometer requires the patient to be in a supine position. Some elderly people are unable to cooperate due to physical reasons, so they cannot perform the detection, or it is difficult to obtain accurate bone density results, which affects the follow-up diagnosis and treatment process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for establishing osteoporosis risk prediction model of type 2 diabetic patient and application thereof
  • Method for establishing osteoporosis risk prediction model of type 2 diabetic patient and application thereof
  • Method for establishing osteoporosis risk prediction model of type 2 diabetic patient and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0029] This embodiment provides a method for establishing a risk prediction model for osteoporosis in patients with type 2 diabetes, the steps comprising:

[0030] S1. Study patients who visited the Department of Endocrinology, Tongji Hospital Affiliated to Tongji University from January 2014 to February 2018. 244 newly diagnosed type 2 diabetic patients and 218 non-diabetic patients who did not use any diabetes drugs or insulin were included. History of fragility fractures, diseases and medications causing secondary osteoporosis, malignant tumors, autoimmune diseases, serum creatinine higher than 100 μmol / L, glutamate pyruvate aminotransferase or aspartate aminotransferase higher than 100 μmol / L were excluded. 80U / L, patients with heart failure and severe lung disease;

[0031] S2. Collect the general information of the above patients (including: age, gender, body mass index, menopausal status, smoking history, drinking history), blood biochemical indicators (including: blood...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of a prediction model in preparation of a kit for predicting osteoporosis risk of a type 2 diabetic patient. The kit comprises a reagent for determining the levelof tartaric acid phosphatase 5b and a reagent for determining the level of osteocalcin; the judgment method of the prediction model is as follows: the disease probability g (x) of osteoporosis is equal to -2.550 + 0.063 * (age) -0.231 * (BMI) + 0.725 * (Menopause) + 0.566 * (TRAP5b) + 0.095 * (OC), wherein age is age, the unit is Year, BMI is a body mass index, and the unit is kg / m < 2 >; the Menopause is in a menopausal state, the value of the Menopause is 1, and the value of the Menopause is not 0; TRAP5b is the level of tartaric acid resistant phosphatase 5b, and the unit is U / L; OC is theosteocalcin level, and the unit is ng / L. The invention has the advantages of being simple, convenient, safe, effective and practical, the fracture risk of the type 2 diabetes patient can be better predicted, prevention and treatment of osteoporosis are started in time, and the life quality of the patient is improved.

Description

technical field [0001] The invention relates to the fields of biotechnology and clinical medicine, in particular to a method for establishing an osteoporosis risk prediction model for patients with type 2 diabetes and its application. Background technique [0002] According to the latest data released by the World Health Organization, the number of diabetic patients worldwide has exceeded 450 million, and its prevalence is gradually increasing as the society ages. Chronic complications such as diabetic nephropathy, retinopathy, neuropathy and cardiovascular disease are the main reasons for its high mortality. Recent evidence suggests that bone fractures are another chronic complication of type 2 diabetes. The longer the duration of type 2 diabetes, the higher the risk of fracture. Patients with type 2 diabetes have a higher risk of fracture than those without type 2 diabetes, and the resulting national health and medical economic problems cannot be underestimated. [0003...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H50/30G16H50/50G06F17/18
CPCG16H50/30G16H50/50G06F17/18
Inventor 宋利格温宇华李慧娟张晓亚刘培培刘奕宸张丽亚张春阳
Owner SHANGHAI TONGJI HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products